William Oak Diagnostics raises £112k for micronutrient testing platform
Published
Developing point-of-care and at-home tests for micronutrient deficiencies, William Oak Diagnostics Limited has secured £112.9k in seed funding. Based in Chatteris, the company operates within the sector of research and experimental development on biotechnology.
The startup provides rapid vitamin testing for women who are trying to conceive, pregnant, or breastfeeding. While maternal health is the primary focus, the technology also aims to serve clinicians and individuals across various clinical groups and B2B markets.
Founded in 2023, the business reported a headcount of six employees for the financial year ended 31 January 2026. This capital injection follows a share allotment in March, with formal documentation filed in June.
Contact the editorial team at [email protected]